Aequus Reports 5th Consecutive Quarter of Revenue Growth
August 27, 2018 08:45 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Closes Balance of $775,000 Equity Financing
August 10, 2018 08:45 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Aug. 10, 2018 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES Aequus Pharmaceuticals Inc. (TSX-V:...
Aequus Announces Fully-subscribed $775,000 Equity Financing
August 09, 2018 08:45 ET
|
Aequus Pharmaceuticals
NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:...
Aequus Announces Closing of $800,000 Equity Financing
July 31, 2018 08:45 ET
|
Aequus Pharmaceuticals
NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, July 31, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:...
Issuance of Stock Options
July 24, 2018 18:00 ET
|
Aequus Pharmaceuticals
VANCOUVER, B.C., July 24, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), Aequus is pleased to announce it has granted incentive stock...
Aequus Announces Proposed $800,000 Equity Financing To Next Edge Biotech Plus Fund
July 23, 2018 08:45 ET
|
Aequus Pharmaceuticals
NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, July 23, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc....
Aequus Announces Expansion of Market Opportunity for its Long Acting Anti-Nausea Transdermal Patch
July 19, 2018 08:45 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, July 19, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”) is pleased to announce a recent expansion of the...
Aequus Extends and Enhances Commercial Agreement to Promote Vistitan in Canada
July 16, 2018 08:45 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, July 16, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), is pleased to announce that it has agreed to new...
Aequus Announces New Independent Director to its Board
July 13, 2018 08:45 ET
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, July 13, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus and Corium Join Forces to Advance Anti-Nausea Transdermal Patch
June 21, 2018 08:45 ET
|
Aequus Pharmaceuticals
Key Highlights Aequus and Corium have expanded their relationship to include Aequus’ long-acting, transdermal patch for nausea and vomiting in pregnancy, AQS1303;Corium will utilize Corplex™, its...